Multiple Sclerosis Therapeutics Market Projected To Witness Substantial Growth, 2025-2032: Biogen Inc., Novartis AG
Multiple Sclerosis Therapeutics Market is estimated to be valued at USD 30.12 Bn in 2024 and is expected to reach USD 39.55 Bn by 2031, exhibiting a CAGR of 4%. BURLINGAME, CA, UNITED STATES, January 7, 2025 /EINPresswire.com/ -- Latest Report, …